Other languages Porton Pharma Solutions Ltd.

Equities

300363

CNE100001S57

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-06-10 pm EDT			5-day change	1st Jan Change
13.89 ^CNY	+2.36%		-2.87%	-44.77%

May. 23	Porton Pharma Solutions Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024	CI
Apr. 26	Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Porton Pharma Solutions Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024	May. 22
Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26
Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 26
Porton Pharma Solutions Ltd. announces an Equity Buyback for CNY 30 million worth of its shares.	23-10-27
Porton Pharma Solutions Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27
Porton Pharma Solutions Ltd. authorizes a Buyback Plan.	23-10-26
Porton Pharma Solutions Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18
Porton Pharma Solutions Ltd. Announces Final Dividend for the Year 2022, Payable on 09 May 2023	23-04-28
Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-21
Porton Pharma Solutions Ltd. Approves Cash Dividend for the Year 2022	23-04-18
Porton Pharma Sees Up to 25% Profit Drop in Q1 on Lower Orders	23-04-03
Porton Pharma Solutions Ltd. Proposes Profit Distribution for 2022	23-03-27
Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-24
Porton Pharma to Build 2.5 Billion Yuan Drug R&D, Production Facility	23-01-20
Porton Pharma Solutions Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25
Porton Pharma Solutions Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-19
Porton Pharma Solutions Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	22-08-04
Porton Pharma Solutions Ltd. authorizes a Buyback Plan.	22-08-03
Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28
Porton Pharma Solutions Ltd. Announces Final Dividend for 2021, Payable on 28 April 2022	22-04-21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Porton Pharma Solutions Ltd.

Equities

300363

CNE100001S57

Other languages

Filters